How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/mastoidectomy-cavity-infections.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Mastoidectomy Cavity Infections — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mastoidectomy Cavity Infections (disease) competitive landscape: 7 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

7 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Mastoidectomy Cavity Infections, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Coly-Mycin S	COLISTIN	Par Sterile Products	colistin	Melanocortin receptor 3	1962-01-01
Coly-Mycin S	tonzonium	Par Sterile Products	tonzonium	Insulin-degrading enzyme	1962-01-01
Cortisporin	NEOMYCIN	Pfizer	Aminoglycoside Antibacterial	Transient receptor potential cation channel subfamily V member 1	1957-01-01
Cortisporin	POLYMYXIN B	Pfizer	Polymyxin-class Antibacterial		1957-01-01
Cortef	hydrocortisone	Generic (originally Merck/Upjohn)	Corticosteroid [EPC]	Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible	1952-01-01
Cortisol	Cortisol	University of Zurich		Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible
colimycin	colimycin	Poitiers University Hospital		Melanocortin receptor 3, Melanocortin receptor 5, Epidermal growth factor receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Par Sterile Products · 2 drugs in Mastoidectomy Cavity Infections
Pfizer · 2 drugs in Mastoidectomy Cavity Infections
· 1 drug in Mastoidectomy Cavity Infections
Generic (originally Merck/Upjohn) · 1 drug in Mastoidectomy Cavity Infections
Poitiers University Hospital · 1 drug in Mastoidectomy Cavity Infections
University of Zurich · 1 drug in Mastoidectomy Cavity Infections

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Mastoidectomy Cavity Infections:

Cite this brief

Drug Landscape (2026). Mastoidectomy Cavity Infections — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/mastoidectomy-cavity-infections. Accessed 2026-06-10.

Mastoidectomy Cavity Infections full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing